Varian launches low-cost radiotherapy product
Varian Medical Systems launches this week a low-energy radiotherapy system with image-guidance and RapidArc volumetric modulated arc therapy technology for international cancer clinics.
Varian launches low-cost radiotherapy product
Varian Medical Systems launches this week a low-energy radiotherapy system with image-guidance and RapidArc volumetric modulated arc therapy technology for international cancer clinics. Dubbed the UNIQUE , the radiotherapy system was unveiled this week at the Biennial ESTRO Conference on Physics and Radiation Technology meeting in Maastrictht, The Netherlands, according to the company. It is designed to make advanced care more affordable and more widely available to cancer patients around the world. The product, which also includes treatment planning and information management software, carries a price tag under $2 million. It is equipped for treating cancers of the head and neck, breast, cervix and prostate, which make up the majority of cases in most areas of the world, Varian said.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
